Self-Managing HIV and Chronic Disease (PRIME)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01032824 |
Recruitment Status
:
Completed
First Posted
: December 16, 2009
Last Update Posted
: October 13, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV/AIDS | Behavioral: Individual Telephone Counseling Intervention Other: Group Arm Other: Book Arm | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 452 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Community-based Self-management of HIV and Chronic Disease |
Study Start Date : | October 2007 |
Actual Primary Completion Date : | February 2011 |
Actual Study Completion Date : | February 2011 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention
Individual telephone counseling intervention.
|
Behavioral: Individual Telephone Counseling Intervention
10-session, 5-month HIV adherence and chronic disease self-management individual telephone counseling intervention.
Other Name: telephone counseling
|
Group Arm
Attention-matched comparison arm
|
Other: Group Arm
10-session didactic telephone group
Other Name: Attention-matched comparison arm
|
Book Arm
Information-matched control arm.
|
Other: Book Arm
Book only.
Other Name: Information-matched comparison arm
|
- antiretroviral (ART) adherence [ Time Frame: Pre-treatment Screening and Baseline, 6, 9, and 12 months f/u. ]
- health-related quality of life (physical, mental health, and social function) [ Time Frame: Baseline, 6, 9, 12 mo f/u ]
- chronic disease treatment adherence [ Time Frame: baseline, 6, 9 and 12 months f/u ]
- Self-efficacy and readiness to change [ Time Frame: baseline, 6, 9, 12 months f/u ]
- perceived stress and depression [ Time Frame: baseline, 6, 9, and 12 months f/u ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age 50 years or older
- HIV-positive serostatus
- currently prescribed antiretroviral medication
- antiretroviral nonadherence reported in past 30 days
- provision of oral informed consent
Exclusion Criteria:
- hearing problems that preclude participation in a telephone study
- presence of probable dementia or acute psychosis detectable by screening interview

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01032824
United States, Washington | |
Group Health Research Institute | |
Seattle, Washington, United States, 98101 |
Principal Investigator: | Sheryl L Catz, PhD | Group Health Research Institute |
Responsible Party: | Kaiser Permanente |
ClinicalTrials.gov Identifier: | NCT01032824 History of Changes |
Other Study ID Numbers: |
5R01MH074380 ( U.S. NIH Grant/Contract ) |
First Posted: | December 16, 2009 Key Record Dates |
Last Update Posted: | October 13, 2017 |
Last Verified: | October 2017 |
Keywords provided by Kaiser Permanente:
Complementary Therapies |
Additional relevant MeSH terms:
Chronic Disease Disease Attributes Pathologic Processes |